Pharma News

Mumbai, Baltimore, April 10, 2019: Pharma major Lupin Limited (Lupin) announced the launch of Fluoxetine Tablets USP, 60mg, having received an approval from the United States Food and Drug Administration (FDA) earlier. Lupin’s Fluoxetine Tablets USP, 60mg, is the generic version of Alvogen Group Holdings 3 LLC’s Fluoxetine Tablets, 60mg. It is indicated in the …

Eribulin will be available in India at approximately 40% cost of the innovator brand Emcure Pharmaceuticals, a leading integrated global pharmaceutical company from India today announced the launch of the world’s first generic version of Eisai Pharmaceutical’s Halaven (Eribulin) for the treatment of metastatic breast cancer (MBC). Emcure will be marketing the drug under brand …

Mumbai, Baltimore, April 03, 2019: Pharma major Lupin Limited (Lupin) announced the successful completion of the United States Food and Drug Administration (U.S. FDA) inspection at its Lupin Bioresearch Centre (LBC) without any observations. rnrnThis is the fifth successive inspection without any 483 observations, indicating superior quality compliance maintained at this global bioresearch facility. rnrnLupin …

Mumbai, April 1, 2019: Pharma major Lupin Limited (Lupin) announced today the appointment of Ms. Christine Mundkur as an Independent Director with immediate effect. Ms. Mundkur most recently served as Chief Executive Officer and Non-voting Chairman of the Board of Directors for Impopharma Inc, a developer of complex formulations focused on inhalation pharmaceutical products. While …

Imaweld® is thermoplastic elastomer opaque tubing designed for fluid transfer in pharmaceutical and biotech applications. Imaweld® is specially formulated which meets requirement of pharmaceutical industries with superiority compare to PVC and silicone. Imaweld® complies with FDA 21 CFR 177.2600, USP Class VI & ISO 10993. It is manufactured & packaged under GMP guidelines in dust …

Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) and Wellthy Therapeutics Private Limited (“Wellthy Therapeutics”) today announced that they have entered into a partnership to offer a combination of pharmacotherapy and digital therapeutics for improved patient outcomes in the chronic therapies of diabetology and cardiology. Under the agreement, a multi-lingual …

Cole-Parmer, a leading manufacturer and supplier of laboratory and industrial products, instrumentation, and supplies recently launched its biggest Pharma Resource Book 2019-20, dedicated to meet application needs of Pharmaceutical and Biopharma customers. For biopharma product development, the pharma resource book addresses the pain areas of the customers such as compliance, SOP concerns, customized solutions, validation …

Mumbai, India, February 7, 2019: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Tadalafil Tablets 20mg from the United States Food and Drug Administration (US FDA). Cipla’s Tadalafil Tablets 20mg is AB-rated generic therapeutic …

Mumbai, India, January 28, 2019: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Medroxyprogesterone Injectable, 150mg/mL from the United States Food and Drug Administration (US FDA). Cipla’s Medroxyprogesterone Injectable, 150mg/mL is AB-rated generic therapeutic …

In a report on 22nd of January 2019 Glenmark Pharmaceuticals said that it has received an USFDA approval for Derma-Smoothe topical oil a generic version drug used for the treatment of Scalp psoriasis. Glenmark Pharmaceuticals Inc, USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (USFDA) for Fluocinolone Acetonide …